“Improvements in Sleep and Pruritus With Abrocitinib Versus Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis: Results From the JADE DARE Study”, J of Skin, vol. 10, no. 3, p. s778, May 2026, doi: 10.25251/03qdfm08.